RT Journal Article
SR Electronic
T1 Correction: ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007766corr1
DO 10.1136/jitc-2023-007766corr1
VO 12
IS 7
YR 2024
UL http://jitc.bmj.com/content/12/7/e007766corr1.abstract